Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
December 21, 2023 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2023 09:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced company...
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
November 08, 2023 09:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
Seer Reports Third Quarter 2023 Financial Results
November 07, 2023 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
November 01, 2023 09:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that Panome Bio...
Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
October 19, 2023 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will...
Seer to Participate in Upcoming September Investor Conferences
September 08, 2023 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company...
Seer Reports Second Quarter 2023 Financial Results
August 08, 2023 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference
July 27, 2023 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
Seer to Report Second Quarter 2023 Financial Results on August 8, 2023
July 13, 2023 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it...